Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.
M MarkusA AbendrothR NoureddineA PaulS BreitenbuecherI VirchowK W SchmidP MarkusB SchumacherM WieswegJ WendlingB MendeJ T SivekeM SchulerStefan KasperPublished in: Journal of cancer research and clinical oncology (2020)
Routinely assessed SIR biomarkers have potential to support therapeutic decision making in patients with metastatic PDAC.